These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12119888)

  • 21. Serious gastrointestinal events from low dose analgesic use.
    Tarone RE; Lipworth L; McLaughlin JK
    J Rheumatol; 2004 May; 31(5):1008-9; author reply 1010-1. PubMed ID: 15124269
    [No Abstract]   [Full Text] [Related]  

  • 22. Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Celecoxib's relative gastrointestinal safety is overstated.
    Metcalfe S; Dougherty S; McNee W
    BMJ; 2003 Feb; 326(7384):334; author reply 334. PubMed ID: 12575714
    [No Abstract]   [Full Text] [Related]  

  • 23. [COX-2 inhibitors: a new treatment in rheumatic diseases].
    Puddu G; Cravero E
    Clin Ter; 2003; 154(1):39-43. PubMed ID: 12854282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-steroidal anti-inflammatory drugs.
    Gøtzsche PC
    Clin Evid; 2002 Jun; (7):1063-70. PubMed ID: 12230727
    [No Abstract]   [Full Text] [Related]  

  • 25. [Capsule endoscopy study of gastrointestinal tolerance. Coxibes superior to NSAID plus antacid].
    MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347082
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of prostaglandins in the pathogenesis of stomach ulcer and gastropathy caused by non-steroid anti-inflammatory drugs].
    Lazebnik LB; Tkachenko VN; Kolomiets EV
    Eksp Klin Gastroenterol; 2005; (1):4-7, 106. PubMed ID: 15991845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Celebra and the CLASS trial--a scandal!].
    Lindberg M
    Ugeskr Laeger; 2002 Nov; 164(46):5407-8; author reply 5408. PubMed ID: 12469395
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacia and Pfizer on the CLASS trial: criticism doesn't give a fair picture of the results].
    Andersson T; Frösing R
    Lakartidningen; 2002 Oct; 99(41):4086. PubMed ID: 12451957
    [No Abstract]   [Full Text] [Related]  

  • 29. NSAIDs and risk of lower gastrointestinal bleeding.
    Rahme E; Bernatsky S
    Lancet; 2010 Jul; 376(9736):146-8. PubMed ID: 20638554
    [No Abstract]   [Full Text] [Related]  

  • 30. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In high risk patients cyclooxygenase inhibitor plus proton pump inhibitor].
    Bolten WW
    MMW Fortschr Med; 2003 Jan; 145(5):9. PubMed ID: 12619199
    [No Abstract]   [Full Text] [Related]  

  • 32. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 33. New drug overview. Celecoxib.
    Am J Health Syst Pharm; 1999 May; 56(10):1031. PubMed ID: 10365731
    [No Abstract]   [Full Text] [Related]  

  • 34. Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials.
    Goldstein JL; Chan FK; Lanas A; Wilcox CM; Peura D; Sands GH; Berger MF; Nguyen H; Scheiman JM
    Aliment Pharmacol Ther; 2011 Oct; 34(7):808-16. PubMed ID: 21810115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standard NSAIDs vs. COX-2 inhibitors.
    Johns Hopkins Med Lett Health After 50; 2002 Jan; 13(11):3. PubMed ID: 14727601
    [No Abstract]   [Full Text] [Related]  

  • 36. Surface phospholipids in gastric injury and protection when a selective cyclooxygenase-2 inhibitor (Coxib) is used in combination with aspirin.
    Lichtenberger LM; Romero JJ; Dial EJ
    Br J Pharmacol; 2007 Apr; 150(7):913-9. PubMed ID: 17325651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aseptic meningitis possibly associated with celecoxib.
    Papaioannides DH; Korantzopoulos PG; Giotis CH
    Ann Pharmacother; 2004 Jan; 38(1):172. PubMed ID: 14742817
    [No Abstract]   [Full Text] [Related]  

  • 38. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
    Håkansson J
    Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
    [No Abstract]   [Full Text] [Related]  

  • 40. Celecoxib-induced upper gastrointestinal hemorrhage and ulceration.
    Crawford AS; White JG
    South Med J; 2002 Dec; 95(12):1444-6. PubMed ID: 12597315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.